SPECTRUM PHARMACEUTICALS INC Quarterly Debt-to-equity in % from Q1 2012 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Spectrum Pharmaceuticals Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Debt-to-equity for the quarter ending March 31, 2023 was 230 %, a 175% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 230 +146 +175% Mar 31, 2023
Q4 2022 164 +92.2 +129% Dec 31, 2022
Q3 2022 138 +81.1 +142% Sep 30, 2022
Q2 2022 103 +55.6 +116% Jun 30, 2022
Q1 2022 83.8 +38.3 +84.4% Mar 31, 2022
Q4 2021 71.3 +27.4 +62.2% Dec 31, 2021
Q3 2021 57.1 +15.3 +36.7% Sep 30, 2021
Q2 2021 47.8 +10.8 +29.3% Jun 30, 2021
Q1 2021 45.4 +13 +40.2% Mar 31, 2021
Q4 2020 44 +13.4 +43.8% Dec 31, 2020
Q3 2020 41.8 +9.01 +27.5% Sep 30, 2020
Q2 2020 37 -0.06 -0.16% Jun 30, 2020
Q1 2020 32.4 -5.95 -15.5% Mar 31, 2020
Q4 2019 30.6 -9.03 -22.8% Dec 31, 2019
Q3 2019 32.7 -5.71 -14.9% Sep 30, 2019
Q2 2019 37.1 -6.26 -14.5% Jun 30, 2019
Q1 2019 38.3 -16.7 -30.4% Mar 31, 2019
Q4 2018 39.6 -27.2 -40.7% Dec 31, 2018
Q3 2018 38.5 -42.3 -52.4% Sep 30, 2018
Q2 2018 43.3 -42.4 -49.5% Jun 30, 2018
Q1 2018 55.1 -26.9 -32.8% Mar 31, 2018
Q4 2017 66.7 -16.8 -20.1% Dec 31, 2017
Q3 2017 80.7 -6.44 -7.39% Sep 30, 2017
Q2 2017 85.7 -8.99 -9.49% Jun 30, 2017
Q1 2017 82 -16 -16.3% Mar 31, 2017
Q4 2016 83.5 -17.1 -17% Dec 31, 2016
Q3 2016 87.2 -12.1 -12.2% Sep 30, 2016
Q2 2016 94.7 -2.38 -2.45% Jun 30, 2016
Q1 2016 98 +5.02 +5.4% Mar 31, 2016
Q4 2015 101 +13.6 +15.7% Dec 31, 2015
Q3 2015 99.3 +16.2 +19.4% Sep 30, 2015
Q2 2015 97.1 +26.5 +37.5% Jun 30, 2015
Q1 2015 93 +25.5 +37.7% Mar 31, 2015
Q4 2014 87 +21.2 +32.3% Dec 31, 2014
Q3 2014 83.1 +17.9 +27.4% Sep 30, 2014
Q2 2014 70.6 -2.92 -3.97% Jun 30, 2014
Q1 2014 67.5 -1.77 -2.56% Mar 31, 2014
Q4 2013 65.8 +3.61 +5.81% Dec 31, 2013
Q3 2013 65.3 +9.37 +16.8% Sep 30, 2013
Q2 2013 73.5 +26.7 +57.1% Jun 30, 2013
Q1 2013 69.3 +15 +27.6% Mar 31, 2013
Q4 2012 62.2 Dec 31, 2012
Q3 2012 55.9 Sep 30, 2012
Q2 2012 46.8 Jun 30, 2012
Q1 2012 54.3 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.